This company seems to have been delisted
Reason: Merged with Sun Pharma
Last recorded trade on: August 23, 2024
Source: https://www.prnewswire.com/news-releases/sun-pharma-completes-taro-merger-302180230.html
Reason: Merged with Sun Pharma
Last recorded trade on: August 23, 2024
Source: https://www.prnewswire.com/news-releases/sun-pharma-completes-taro-merger-302180230.html
Taro Pharmaceutical
TARO
NZ$72.10
Share price
0.00%
Change (1 day)
7.13%
Change (1 year)
Categories
Taro Pharmaceutical (TARO) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : NZ$0.64 Billion
According to Taro Pharmaceutical's latest financial reports the company's total liabilities are NZ$0.64 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Taro Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-03-31 | NZ$0.64 B | -3.63% |
| 2022-03-31 | NZ$0.67 B | -34.18% |
| 2021-03-31 | NZ$1.01 B | 161.89% |
| 2020-03-31 | NZ$0.38 B | 18.39% |
| 2019-03-31 | NZ$0.32 B | 6.7% |
| 2018-03-31 | NZ$0.30 B | 0.01% |
| 2017-03-31 | NZ$0.30 B | -15.06% |
| 2016-03-31 | NZ$0.36 B | -15.75% |
| 2015-03-31 | NZ$0.43 B | 41.53% |
| 2014-03-31 | NZ$0.30 B | 18.07% |
| 2013-03-31 | NZ$0.25 B | |
| 2011-12-31 | NZ$0.28 B | 29.24% |
| 2010-12-31 | NZ$0.22 B | -42.23% |
| 2009-12-31 | NZ$0.38 B | -27.52% |
| 2008-12-31 | NZ$0.53 B | 23.51% |
| 2007-12-31 | NZ$0.43 B | -19.02% |
| 2006-12-31 | NZ$0.53 B | -13.43% |
| 2005-12-31 | NZ$0.61 B | 33.71% |
| 2004-12-31 | NZ$0.45 B | 11.75% |
| 2003-12-31 | NZ$0.41 B | 96.53% |
| 2002-12-31 | NZ$0.20 B | -1.92% |
| 2001-12-31 | NZ$0.21 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | NZ$196.97 B | 30,463.73% | 🇺🇸 USA |
 Merck MRK | NZ$111.95 B | 17,271.63% | 🇺🇸 USA |
 Johnson & Johnson JNJ | NZ$193.90 B | 29,987.53% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | NZ$53.93 B | 8,269.48% | 🇮🇱 Israel |
 GlaxoSmithKline GSK | NZ$102.00 B | 15,728.25% | 🇬🇧 UK |
 Novartis NVS | NZ$103.17 B | 15,909.18% | 🇨🇭 Switzerland |